logo

Human Technology Assessment for HPV Vaccine

Examining the cost-effectiveness of adding a human papillomavirus vaccine to the Australian National Cervical Screening Program compared to screening alone.

10 Pages2238 Words299 Views
   

Added on  2023-06-03

About This Document

This study critically assesses the HPV vaccine for the treatment of different types of cancer and warts. It examines the evidence relating to decision making, clinical evidence, economic considerations, uncertainties, and recommendations for Australia.

Human Technology Assessment for HPV Vaccine

Examining the cost-effectiveness of adding a human papillomavirus vaccine to the Australian National Cervical Screening Program compared to screening alone.

   Added on 2023-06-03

ShareRelated Documents
Running head: HUMAN TECHNOLOGY ASSESSMENT
Human Technology Assessment
Name of the Student:
Name of the University:
Author Note:
Human Technology Assessment for HPV Vaccine_1
1HUMAN TECHNOLOGY ASSESSMENT
Abstract
This study is based on the critical assessment of a health technology and for this purpose, HPV
vaccine is considered for the treatment of different types of cancer and warts. As per the
findings, the HPV vaccination program is one of the cost ways of eradicating the HPV
infections. The funds or the budget allocation are well between the range of budgetary
allocations and it is beneficial for the girls, women in comparison to the girls. Australian
government can take up the policy of conducting herd vaccination and this will be cost effective
in comparison to the single screening methods.
Human Technology Assessment for HPV Vaccine_2
2HUMAN TECHNOLOGY ASSESSMENT
Table of Contents
Introduction......................................................................................................................................3
Human Papillomavirus vaccine.......................................................................................................3
Evidence relating to decision making..............................................................................................4
Evidence relating to clinical evidence.............................................................................................5
Evidence related to the key components of economic considerations............................................5
Uncertainties related to HPV vaccine..............................................................................................6
Recommendation and applicability in Australia..............................................................................6
Conclusion.......................................................................................................................................7
Reference.........................................................................................................................................8
Human Technology Assessment for HPV Vaccine_3

End of preview

Want to access all the pages? Upload your documents or become a member.

Related Documents
Environmental scanning as a public health tool for HPV vaccination
|2
|756
|209

Factors Influencing Parental Decisions about HPV Vaccination
|55
|10165
|73

Health Technology Assessment for Human Papillomavirus Vaccine
|20
|2670
|187

Immunisation: Preventing Sexual Transmitted Diseases through Vaccination
|5
|646
|447

HPV Vaccination in Nicaragua: Pushing a Priority or Setting an Agenda?
|3
|1236
|169

How to set a clear presentation objective
|19
|738
|14